Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03176849
What this trial is testing

Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT

Who this might be right for
Vitamin D DeficiencyStem Cell Transplant ComplicationsPediatric Cancer+7 more
Phoenix Children's Hospital 49
Early research (Phase 1)Study completedNCT01342289
What this trial is testing

Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

Who this might be right for
Hodgkin's LymphomaLeukemiaMyelodysplastic Syndrome(MDS)+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976
What this trial is testing

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more
National Cancer Institute (NCI) 282
Testing effectiveness (Phase 2)Looking for participantsNCT03999723
What this trial is testing

Combining Active and Passive DNA Hypomethylation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Kirsten Grønbæk 196
Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Early research (Phase 1)WithdrawnNCT02487459
What this trial is testing

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Bellicum Pharmaceuticals
Early research (Phase 1)Active Not RecruitingNCT05455294
What this trial is testing

Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms

Who this might be right for
Myeloid MalignancyMyelodysplastic SyndromesMyelofibrosis+2 more
Jacqueline Garcia, MD 16
Testing effectiveness (Phase 2)UnknownNCT04964518
What this trial is testing

APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
AML, Adult
Ascentage Pharma Group Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02131597
What this trial is testing

Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes

Who this might be right for
High Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center 100
Not applicableActive Not RecruitingNCT04482894
What this trial is testing

Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS

Who this might be right for
Leukemia, AcuteAML, AdultALL, Adult+1 more
University of Virginia 105
Testing effectiveness (Phase 2)Ended earlyNCT04878432
What this trial is testing

STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS

Who this might be right for
Myelodysplastic Syndrome (MDS)
Novartis Pharmaceuticals 39
Not applicableUnknownNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Testing effectiveness (Phase 2)UnknownNCT02856464
What this trial is testing

Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
King's College Hospital NHS Trust 124
Early research (Phase 1)Study completedNCT03787498
What this trial is testing

PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Relapsed Acute Myeloid Leukemia (AML)Refractory Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)
Opna Bio LLC 22
Post-approval studies (Phase 4)Study completedNCT01201811
What this trial is testing

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Celgene 44
Large-scale testing (Phase 3)Ended earlyNCT04266301
What this trial is testing

Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Novartis Pharmaceuticals 530
Testing effectiveness (Phase 2)Ended earlyNCT03151304
What this trial is testing

A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Helsinn Healthcare SA 64
Testing effectiveness (Phase 2)Study completedNCT01305135
What this trial is testing

Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes

Who this might be right for
High Grade Myelodysplastic Syndrome Lesions
Groupe Francophone des Myelodysplasies 41
Testing effectiveness (Phase 2)Ended earlyNCT00666497
What this trial is testing

Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Mirati Therapeutics Inc. 6
Testing effectiveness (Phase 2)WithdrawnNCT02204020
What this trial is testing

Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
University of Pittsburgh
Next Page